Literature DB >> 7547218

Plasma chromogranin A marks emesis and serotonin release associated with dacarbazine and nitrogen mustard but not with cyclophosphamide-based chemotherapies.

L X Cubeddu1, D T O'Connor, I Hoffmann, R J Parmer.   

Abstract

Chromogranin A (CgA) is present in high concentrations in enterochromaffin cells, where it is co-localised with serotonin in the storage granules. Plasma CgA has been reported to mark emesis and serotonin release associated with cisplatin treatment. However, it is not known whether plasma CgA could be an indicator of emesis and of serotonin release in patients receiving non-cisplatin chemotherapies. Therefore, in this study we evaluated, in cancer patients, the temporal relationships between the increases in plasma CgA and urinary 5-hydroxyindoleacetic acid (5-HIAA) and the development of vomiting following dacarbazine, nitrogen mustard and cyclophosphamide treatments. Metoclopramide was used as antiemetic. With dacarbazine, nitrogen mustard and cyclophosphamide the median time to the onset of emesis was 2.3, 2.8 and 5.3 h and the duration of intense emesis was 3, 2 and 6 h respectively. Plasma CgA and urinary 5-HIAA increased after dacarbazine- and nitrogen mustard-based chemotherapies, with maximal increases between 4 and 6 h after initiation of drug infusion. The time course for the increases in plasma CgA paralleled that of urinary 5-HIAA and the period of intense emesis. A highly significant (P = 0.0009) positive correlation (r = 0.68) was found between the increases in plasma CgA and in urinary 5-HIAA. Cyclophosphamide treatment was not associated with increases in plasma CgA and in urinary 5-HIAA, despite inducing emesis; this indicates that the increases in CgA and 5-HIAA after dacarbazine and nitrogen mustard are not due to the act of vomiting per se. In summary, plasma CgA is a marker of serotonin release (most likely from enterochromaffin cells) after dacarbazine and nitrogen mustard-based chemotherapies, exocytosis being the most likely mechanism for the release of serotonin. Serotonin released from enterochromaffin cells seems to trigger the emetic response to dacarbazine and nitrogen mustard; however, cyclophosphamide may release serotonin from a different pool (enteric serotonin neurons and/or CNS serotonin?).

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7547218      PMCID: PMC2034062          DOI: 10.1038/bjc.1995.457

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  21 in total

1.  Chromogranin: a newly recognized marker for endocrine cells of the human gastrointestinal tract.

Authors:  P Facer; A E Bishop; R V Lloyd; B S Wilson; R J Hennessy; J M Polak
Journal:  Gastroenterology       Date:  1985-12       Impact factor: 22.682

2.  Efficacy of ondansetron (GR 38032F) and the role of serotonin in cisplatin-induced nausea and vomiting.

Authors:  L X Cubeddu; I S Hoffmann; N T Fuenmayor; A L Finn
Journal:  N Engl J Med       Date:  1990-03-22       Impact factor: 91.245

3.  Chromogranin A: studies in the endocrine system.

Authors:  D T O'Connor; R J Parmer; L J Deftos
Journal:  Trans Assoc Am Physicians       Date:  1984

4.  Ultrastructural localization of chromogranin: a potential marker for the electron microscopical recognition of endocrine cell secretory granules.

Authors:  I M Varndell; R V Lloyd; B S Wilson; J M Polak
Journal:  Histochem J       Date:  1985-09

5.  Rapid radioimmunoassay of circulating chromogranin A: in vitro stability, exploration of the neuroendocrine character of neoplasia, and assessment of the effects of organ failure.

Authors:  D T O'Connor; M R Pandlan; E Carlton; J H Cervenka; R J Hslao
Journal:  Clin Chem       Date:  1989-08       Impact factor: 8.327

6.  Participation of serotonin on early and delayed emesis induced by initial and subsequent cycles of cisplatinum-based chemotherapy: effects of antiemetics.

Authors:  L X Cubeddu; I S Hoffmann
Journal:  J Clin Pharmacol       Date:  1993-08       Impact factor: 3.126

7.  Immunoreactivities for chromogranin A and B, and secretogranin II in the guinea pig entero-endocrine system: cellular distributions and intercellular heterogeneities.

Authors:  Y Cetin; D Grube
Journal:  Cell Tissue Res       Date:  1991-05       Impact factor: 5.249

8.  Efficacy of oral ondansetron, a selective antagonist of 5-HT3 receptors, in the treatment of nausea and vomiting associated with cyclophosphamide-based chemotherapies. Ondansetron Study Group.

Authors:  L X Cubeddu; K Pendergrass; T Ryan; M York; G Burton; M Meshad; D Galvin; A A Ciociola
Journal:  Am J Clin Oncol       Date:  1994-04       Impact factor: 2.339

9.  Changes in serotonin metabolism in cancer patients: its relationship to nausea and vomiting induced by chemotherapeutic drugs.

Authors:  L X Cubeddu; I S Hoffmann; N T Fuenmayor; J J Malave
Journal:  Br J Cancer       Date:  1992-07       Impact factor: 7.640

Review 10.  The chromogranins A and B: the first 25 years and future perspectives.

Authors:  H Winkler; R Fischer-Colbrie
Journal:  Neuroscience       Date:  1992-08       Impact factor: 3.590

View more
  6 in total

1.  5-Hydroxyindoleacetic acid excretion following combination chemotherapy with cyclophosphamide, epirubicin and 5-fluorouracil plus ondansetron compared to ondansetron alone.

Authors:  A du Bois; W Vach; R Holy; H Kriesinger-Schröder
Journal:  Support Care Cancer       Date:  1996-09       Impact factor: 3.603

2.  The relationship between perioperative nausea and vomiting and serum serotonin concentrations in patients undergoing cesarean section under epidural anesthesia.

Authors:  Byung Gun Lim; Sang-Sik Choi; Yu Jin Jeong; Young Jin Lim; Yong Chul Kim; Kyoung Un Park; Dong Kyu Lee; Mi Kyoung Lee
Journal:  Korean J Anesthesiol       Date:  2014-12-29

Review 3.  Physiology of chemotherapy-induced emesis and antiemetic therapy. Predictive models for evaluation of new compounds.

Authors:  C Veyrat-Follet; R Farinotti; J L Palmer
Journal:  Drugs       Date:  1997-02       Impact factor: 9.546

Review 4.  Systemic treatment-induced gastrointestinal toxicity: incidence, clinical presentation and management.

Authors:  Stergios Boussios; George Pentheroudakis; Konstantinos Katsanos; Nicholas Pavlidis
Journal:  Ann Gastroenterol       Date:  2012

5.  Anti-emetic mechanisms of Zingiber officinale against cisplatin induced emesis in the pigeon; behavioral and neurochemical correlates.

Authors:  Ihsan Ullah; Fazal Subhan; Muhammad Ayaz; Rehmat Shah; Gowhar Ali; Ikram Ul Haq; Sami Ullah
Journal:  BMC Complement Altern Med       Date:  2015-02-26       Impact factor: 3.659

6.  Suppression of Cisplatin-Induced Vomiting by Cannabis sativa in Pigeons: Neurochemical Evidences.

Authors:  Ihsan Ullah; Fazal Subhan; Javaid Alam; Muhammad Shahid; Muhammad Ayaz
Journal:  Front Pharmacol       Date:  2018-03-16       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.